HY
HYPR.US Hyperfine Inc
- Market cap
- USD 66.7M
- P/E
- -
- P/B
- 2.08x
- ROE
- -100.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is HYPR.US undervalued?
Graham numberThe Graham number of Hyperfine Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Hyperfine Inc fundamental analysis
No fundamental analysis for Hyperfine Inc yet.
Hyperfine Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Hyperfine Inc
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offic…
Full company profileHyperfine Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Hyperfine Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 294K | 1.50M | 6.81M | 11.0M | 12.9M | 13.6M | 18.4M |
| Gross Profit | 0.00 | -477K | -1.17M | 907K | 4.76M | 5.89M | 6.75M | 9.79M |
| Operating Income | -20.0M | -23.5M | -64.9M | -73.9M | -48.1M | -43.2M | -37.1M | -32.4M |
| EBITDA | -19.8M | -23.2M | -64.1M | -72.1M | -43.2M | -39.7M | -34.5M | -29.6M |
| Net Income | -18.8M | -23.4M | -64.8M | -73.2M | -44.2M | -40.7M | -35.6M | -31.9M |
| EPS | -4.06 | -0.93 | -0.92 | -1.04 | -0.62 | -0.56 | -0.38 | -0.30 |
| Balance Sheet | ||||||||
| Total Assets | 30.6M | 71.5M | 202M | 134M | 94.2M | 58.9M | 55.3M | 57.8M |
| Total Liabilities | 1.79M | 4.29M | 16.2M | 10.3M | 9.80M | 9.86M | 14.3M | 26.0M |
| Shareholders' Equity | 28.8M | 67.2M | 186M | 124M | 84.4M | 49.0M | 41.0M | 31.7M |
| Cash & Short-term Investments | 26.4M | 62.7M | 188M | 118M | 75.2M | 37.6M | 35.1M | 37.9M |
| Total Debt | - | 178K | - | - | 185K | 269K | 314K | 13.8M |
| Cash Flow | ||||||||
| Operating Cash Flow | -18.4M | -21.5M | -47.2M | -72.3M | -41.8M | -38.8M | -27.9M | -29.8M |
| Capital Expenditure | 244K | 1.57M | 2.71M | 585K | 804K | 383K | 1.19M | 391K |
| Free Cash Flow | -18.6M | -23.1M | -49.9M | -72.9M | -42.6M | -39.2M | -29.1M | -30.2M |
| Ratios | ||||||||
| ROE | -65.3% | -34.7% | -34.8% | -59.1% | -52.4% | -83.0% | -86.8% | -100.4% |
| ROA | -61.4% | -32.7% | -32.0% | -54.6% | -47.0% | -69.1% | -64.4% | -55.1% |
| Net Profit Margin | - | -7,944.6% | -4,333.8% | -1,073.7% | -401.0% | -315.9% | -262.3% | -173.6% |
| Debt to Equity | - | 0.00x | - | - | 0.00x | 0.01x | 0.01x | 0.43x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Hyperfine Inc dividends
Hyperfine Inc has not paid dividends in the last 7 fiscal years.
Who owns Hyperfine Inc
- Insiders 4.48%
- Institutions 22.09%
- Public & others 73.43%
- Shares outstanding 91.0M
- Free float 86.6M
Top funds holding HYPR.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.34M | 2.20% | 0.00% | Sep 2026 |
| iShares Russell 2000 ETF | 1.65M | 1.55% | 0.00% | Oct 2026 |
| Fidelity Small Cap Index | 860K | 0.81% | +1.38% | Aug 2026 |
| iShares Russell 2000 Growth ETF | 744K | 0.70% | -0.38% | Oct 2026 |
| Bridge Builder Small Cap Fund | 726K | 0.68% | 0.00% | Oct 2026 |
| Vanguard Russell 2000 ETF | 452K | 0.43% | -0.02% | Sep 2026 |
| Fidelity Extended Market Index | 429K | 0.40% | -0.38% | Sep 2026 |
| Russell Inv US Small Cap Equity Y | 280K | 0.26% | +139.20% | Sep 2026 |
| iShares Micro-Cap ETF | 238K | 0.22% | 0.00% | Oct 2026 |
| Schwab Small Cap Index | 190K | 0.18% | 0.00% | Sep 2026 |
| iShares Russell 2000 Small-Cap Idx Instl | 146K | 0.14% | 0.00% | Sep 2026 |
| Fidelity Total Market Index | 141K | 0.13% | 0.00% | Sep 2026 |
| Fidelity Series Total Market Index | 122K | 0.11% | 0.00% | Sep 2026 |
| Nuveen Small Cap Blend Idx R6 | 103K | 0.10% | 0.00% | Sep 2026 |
| EA Bridgeway Ultra-Small Company Mkt ETF | 95.2K | 0.09% | 0.00% | Oct 2026 |
| Vanguard Russell 2000 Growth ETF | 85.0K | 0.08% | 0.00% | Sep 2026 |
| Fidelity Small Cap Growth Index | 83.6K | 0.08% | +5.89% | Aug 2026 |
| EQ/2000 Managed Volatility IB | 81.2K | 0.08% | 0.00% | Sep 2026 |
Top institutions holding HYPR.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 4.67M | 4.40% | +712.85% | Jun 2026 |
| Vanguard Capital Management, LLC | 3.38M | 3.18% | -2.12% | Jun 2026 |
| Geode Capital Management, LLC | 1.96M | 1.85% | +105.26% | Jun 2026 |
| Fosun International Ltd | 1.74M | 1.64% | 0.00% | Sep 2026 |
| Catalio Capital Management, LP | 1.32M | 1.24% | 0.00% | Jun 2026 |
| State Street Corp | 1.02M | 0.96% | +213.81% | Jun 2026 |
| Alphabet Inc | 899K | 0.85% | 0.00% | Jun 2026 |
| Renaissance Technologies Corp | 716K | 0.67% | -24.34% | Sep 2026 |
| Northern Trust Corp | 633K | 0.60% | +256.92% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 567K | 0.53% | +7.67% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 547K | 0.52% | 0.00% | Jun 2026 |
| HRT FINANCIAL LLC | 374K | 0.35% | 0.00% | Jun 2026 |
| Marshall Wace Asset Management Ltd | 342K | 0.32% | 0.00% | Jun 2026 |
| Two Sigma Investments LLC | 326K | 0.31% | 0.00% | Jun 2026 |
| ISTHMUS Partners LLC | 313K | 0.30% | 0.00% | Sep 2026 |
| Bank of New York Mellon Corp | 310K | 0.29% | +123.37% | Jun 2026 |
| Gwn Securities Inc | 275K | 0.26% | 0.00% | Jun 2026 |
| Charles Schwab Investment Management Inc | 190K | 0.18% | 0.00% | Jun 2026 |
| HighTower Advisors, LLC | 187K | 0.18% | 0.00% | Jun 2026 |
| Bridgeway Capital Management, LLC | 128K | 0.12% | +7.27% | Jun 2026 |
Hyperfine Inc company profile
- Company name
- Hyperfine Inc
- Ticker
- HYPR.US
- Exchange
- USA Stocks
- Listed since
- Jan 27, 2021
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 102
- Fiscal year end
- December
- Address
- 351 New Whitfield Street, Guilford, CT, United States, 06437
- Phone
- 866 796 6767
- Website
- hyperfinemri.com
About Hyperfine Inc
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.
Hyperfine Inc management
10- Ms. Maria Degois-SainzCEO, President & Director · born 1966
- Dr. Jonathan M. Rothberg Ph.D.Founder & Vice Chairman · born 1964
- Mr. Brett HaleChief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Corporate Secretary · born 1974
- Dr. Thomas Teisseyre Ph.D.Chief Operating Officer · born 1984
- Rafael O'HalloranVice President of Technology
- Dr. Leslie Grab J.D., Ph.D.General Counsel
- Mr. Chip Truwit FACR, M.D.Senior Vice President of Office Strategy and Partnerships
- Mr. Edmond Knopp M.D.Chief Medical Officer
- Rafael DonnaySenior Vice President of Hospital Business
- Mr. Rob Fasciano Ph.D.Chief Regulatory & Quality Officer